86-21-64556180

cpd-service@caerulumpharma.com

Home
About Us
Products
Solutions
FAQs
Contact Us

Home
8 – Uridine Cas:58-96-8

Products Categories

Antineoplastic
- ACC
- Adenosine A2A
- ALK
- Androgen receptor inhibitor
- Apoptosis stimulant
- ATR
- AXL
- BCl2-BH4
- Bcr-Abl
- BRAF
- BTK
- CDK
- Chk1
- CYP17
- DNA alkylating agent
- EED
- EGFR
- EP4
- ER
- FAK
- FGFR
- FLT3
- Glutaminase
- IDO
- IRA
- KIT
- LXR
- MDM2
- MEK
- MET
- Nrf2
- P90RSK
- P97
- PAKS
- PARP
- PI3K
- Plk-1
- SMYD2
- SRC
- TOPK
- VEGFR
Hypoglycemic drugs
- DPP-4
- SGLT-1
- SGLT-2
Others
- 5HT
- AMPK
- Arginase
- CRF-1
- CXCR2
- FLAP
- FXR
- GABA
- Gi activator
- GR
- JAK
- LABA
- mAChRs
- NF-κB
- NRTI
- PPAR
- RIP1
- S1PR
- SGC
- SYK
- α2δ-1
- αIIbβ3
- β2-adrenoceptor
- σ1

8 – Uridine Cas:58-96-8 - Manufacturers, Factory, Suppliers From China

8 – Uridine Cas:58-96-8, , , , 8 – Uridine Cas:58-96-8,

Popular Design for 918633-87-1 - Derazantinib;...
2018 China New Design 1 Ibrutinib Powder –...
factory Outlets for 2-acetamido-4-methylpentano...
Personlized Products Medical Raw Material - GS...
Massive Selection for High Purity Bromocriptine...
Top Quality MAK 683 - Verucerfont – Caer...
Rapid Delivery for 2 – Posaconazole Price...
OEM/ODM China Amprolium Hydrochloride Powder - ...
Factory For Methyl Salicylate - Olodaterol Fre...
OEM Factory for CPI 444 - PQR530 – Caer...
New Delivery for Zykadia - PQR530 – Cae...
Supply OEM High Quality Curcumin Antineoplastic...
Factory wholesale Micronized Progesterone Powde...
OEM/ODM Factory 27-1 – Cisplatin - BAY 6...

Contact Us

3rd Floor, Building 4, 3918 Daye Road, Fengxian District, Shanghai
86-21-64556180
Within China:
sales-cpd@caerulumpharma.com
International:
cpd-service@caerulumpharma.com

Inquiry

For inquiries about our products, please leave your email with us and we will be in touch within 24 hours.Inquiry

Latest News

Top 7 Trends In Pharmaceutical Research I...

Being under ever-increasing pressure to compete in a challenging economic and technological environment, pharmaceutical and biotech companies must continually innovate in their R&D programmes to stay ahead ...
ARS-1620: A promising new inhibitor for K...

According to a study published in Cell, researchers have developed a specific inhibitor for KRASG12C called ARS-1602 that induced tumor regression in mice. “This study provides in vivo evidence that mutant KRAS can be...
AstraZeneca receives regulatory boost for...

AstraZeneca received a double boost for its oncology portfolio on Tuesday, after US and European regulators accepted regulatory submissions for its drugs, the first step towards winning approval for these medicines. ...

FAQs
Downloadable
Contact Us

QR Code

WhatsApp Online Chat !